Demazin

   
Google
 
Web NewDrugInformation.com

Demazin


Drug - Demazin
The trade name of the product as shown on the labeling.

Dosage - TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 4MG;25MG
The potency of the active ingredient(s), Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride. May repeat for multiple part products.

Applicant - SCHERING PLOUGH
The firm name holding legal responsibility for Demazin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018556
The FDA assigned number to Demazin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Demazin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 14, 1984
The date Demazin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Demazin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Demazin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Schering Plough Healthcare Products Inc
The full name of the firm holding legal responsibility for the new application of Demazin.

Demazin